Difficulty: Medium
Average Score: 72%
Practice
The following prostanoid is a potent inducer of platelet aggregation
Correct answer
D
Rationale
The correct answer is D) Thromboxane A2. Thromboxane A2 is a potent inducer of platelet aggregation. It is synthesized by activated platelets and plays a crucial role in hemostasis by promoting platelet activation and aggregation at the site of vascular injury.
Prostacyclin (A) is a vasodilator and inhibitor of platelet aggregation, working in opposition to thromboxane A2. Prostaglandin E2 (B) and Prostaglandin D2 (C) also have anti-aggregatory effects and do not induce platelet aggregation like thromboxane A2.
In an educational context, understanding the pharmacology of prostanoids is important in various fields such as cardiology, hematology, and pharmacology. Knowing the specific roles of different prostanoids can help healthcare professionals make informed decisions regarding antiplatelet therapy in conditions like myocardial infarction, stroke, and peripheral vascular disease. Understanding the functions of these molecules is crucial for providing effective patient care and preventing adverse cardiovascular events.
Prostacyclin (A) is a vasodilator and inhibitor of platelet aggregation, working in opposition to thromboxane A2. Prostaglandin E2 (B) and Prostaglandin D2 (C) also have anti-aggregatory effects and do not induce platelet aggregation like thromboxane A2.
In an educational context, understanding the pharmacology of prostanoids is important in various fields such as cardiology, hematology, and pharmacology. Knowing the specific roles of different prostanoids can help healthcare professionals make informed decisions regarding antiplatelet therapy in conditions like myocardial infarction, stroke, and peripheral vascular disease. Understanding the functions of these molecules is crucial for providing effective patient care and preventing adverse cardiovascular events.